Western blotting analysis revealed the downregulation of SLC22A1 protein expression in four HCC cell lines (Huh7, SK-Hep-1, SNU449, and SNU398) compared with that in normal hepatocytes (THLE-3) (Fig. 10C). Here, SLC22A1 is linked to hepatocellular carcinoma.